Cellyan Biotechnology (HKPD) Assets (2024 - 2026)
Cellyan Biotechnology (HKPD) posted quarterly Assets of $9.6 million for Q3 2025, down 5.2% year-over-year from $10.2 million in Q3 2024, and up 2.3% quarter-over-quarter from $9.4 million in Q1 2025.
Cellyan Biotechnology (HKPD) Assets (2024 - 2026) Analysis & Trends
Cellyan Biotechnology (HKPD) has reported Assets for 2 consecutive years, with $9.6 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Assets fell 5.2% year-over-year to $9.6 million; the TTM figure through Sep 2025 stood at $9.6 million (down 5.2% YoY), while the FY2025 annual figure was $9.4 million, up 8.65% from the prior year.
- Assets improved to $9.6 million in Q3 2025 per HKPD's latest filing, from $9.4 million in the prior quarter.
- Across five years, Assets topped out at $10.2 million in Q3 2024 and bottomed at $8.7 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 88.33 Bn |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 83.81 Bn |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 57.30 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 11.38 Bn |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | 189.63 Mn |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | 74.55 Mn |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | 2.11 Bn |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | 280.49 Mn |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | 61.46 Mn |
| 10 | Cellyan Biotechnology | 6.55 Mn | 6.32 Mn | - | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.84 Mn |
| Sep 30, 2025 | 9.63 Mn |
| Mar 31, 2025 | 9.42 Mn |
| Sep 30, 2024 | 10.16 Mn |
| Mar 31, 2024 | 8.67 Mn |